Differentiating chronic obstructive pulmonary disease from asthma.

Purpose: Chronic obstructive pulmonary disease (COPD) and asthma are chronic diseases that are increasing worldwide in incidence, prevalence, and burden. The purpose of this article is to provide nurse practitioners (NPs) with the information necessary to make a differential diagnosis and to understand the different treatment approaches to these two diseases.

Data Sources: Peer-reviewed journal articles, book chapters, and evidence-based Internet sources.

Meeting Joint Commission on Accreditation of Healthcare Organizations requirements for tobacco cessation: the St. Joseph's/Candler Health System approach to success.

Health care institutions can no longer treat only the sequelae of tobacco use. Smoking-cessation programs must be instituted to meet health promotion and education goals developed on admission for all patients. Leading authorities, such as the Joint Commission on Accreditation of Health Care Organizations and the Centers for Medicare and Medicaid Services, now include tobacco-cessation counseling as quality performance measures.

Potential reduction exposure products and FDA tobacco and regulation: a CNS call to action.

A new generation of tobacco harm reduction products is stirring controversy and confusion among healthcare providers. These products, known as "potential reduction exposure products" (PREPs), can be described in terms of reported scientific evidence, as "the good, the bad, and the ugly." On the good side, there is sufficient scientific evidence to support the use of Commit, a new over-the-counter nicotine lozenge PREP, approved for smoking cessation.